BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 19, 2004
View Archived Issues
Immunicon Raises $48M In IPO; Lower Pricings Trend Continues
Following a recent trend of lower-than-expected pricings, Immunicon Corp. stepped up to the initial public offering plate on Friday, raising a total of $48 million. (BioWorld Today)
Read More
Cytogen Brings In $26M To Increase Sales Force Size
Read More
Panel Discusses Potential Ways To Improve FDA Approval Cycle
Read More
Hybridon Signs Deal To Raise $11.8M For Cancer, HIV Drugs
Read More
Other News To Note
Read More